#422: ISO 14971 and the Road to Risk Management with Edwin Bills

Global Medical Device Podcast · 1 Sept 2025 · 1h 03m · Episode 422

What this episode covers

Edwin Bills, a lead expert in medical device risk management and key contributor to ISO 14971, explains how his background as a submariner and manufacturing quality engineer informs his approach to patient safety and cost of quality. He details the critical link between manufacturing process capability (CPK), supplier quality, and financial risk, arguing that quality failures directly impact a company's bottom line and reputation. Bills critiques common industry practices, such as late-stage FMEA and manual spreadsheet-based traceability, advocating for early hazard analysis, industrial statistics, and integrated software solutions to manage complex risks in medical devices and combination products.

Other shows on the same ground, closest first.

  • Let's Combinate · 1h 31m

    025 - “The Frying Pan to the Fire” with Edwin Bills

    Edwin Bills, a Risk Management Expert and former committee member for ISO 14971, ISO TR 24971, and AAMI TIR 105, explains the evolution of risk management standards in medical devices and combination products. He details the philosophical differences between ISO 14971 and ICH Q9, emphasizing that risk management must focus on patient safety rather than just regulatory compliance. Bills advises engineers to use qualitative methods early in development and highlights the importance of analyzing interactions between drug and device constituents in combination products. He also discusses the expanded requirements for post-market surveillance in the 2019 standard and the upcoming harmonization of ISO 14971 in Europe.

  • Let's Combinate · 32m

    202 - Becoming an Expert in the Work Nobody Wants to Do/Design, Risk, and the Messy Middle of Combination Products w/Joey Frechin

    Joey Frechin, a Senior Technical Program Manager in med tech consulting, explains the complexities of aligning risk assessments for combination products, noting that while drug and device teams are starting to integrate their processes, significant methodological gaps remain. He details the P1/P2 probability scoring methodology used in ISO 14971 to distinguish between device failure and patient harm, and shares his career strategy of becoming an expert in 'unwanted' but high-value tasks like DFMEA and PFMEA to bridge engineering and quality teams. Frechin also discusses current industry trends, where companies often pivot from complex bespoke designs to simplified or off-the-shelf subsystems to meet clinical trial timelines, highlighting the critical importance of early sterilization and accelerated aging testing to avoid late-stage failures.

  • Let's Combinate · 24m

    161 - ISO 14971 and ICH Q9 EXPLAINED: Risk Management Frameworks in Medical Devices, Pharma and Combination Products

    Host Subhi Saadeh explains the distinct yet complementary roles of ISO 14971 and ICH Q9 in managing risk for combination products, highlighting how ISO 14971 focuses on patient safety through lifecycle management while ICH Q9 addresses broader pharmaceutical quality risks. He details the recent updates in ICH Q9 R1, particularly regarding managing subjectivity and scaling formality, and contrasts the structured, plan-driven approach of device risk management with the more collaborative, problem-driven nature of pharma risk assessments. Saadeh emphasizes critical concepts unique to ISO 14971, such as 'state of the art' for residual risk evaluation and the dual verification of implementation and effectiveness, which are essential for ensuring safety in complex drug-device combinations.

  • Let's Combinate · 43m

    095 - How FMEA fits into ISO14971, Probabilities, Severity of Harm, RPN's, pFMEA's and making it simpler with Naveen Agarwal

    Naveen Agarwal of Creative Analytics Solutions explains that ISO 14971 does not mandate FMEA, arguing that industry misuse of the tool for compliance rather than engineering reliability creates gaps in patient safety. He distinguishes between the 'one-to-many' nature of FMEA and the 'many-to-one' reality of patient harm, advocating for the use of Fault Tree and Event Tree analyses to bridge this gap. Agarwal emphasizes that severity in FMEA should prioritize engineering outcomes beyond just safety, and that process FMEAs must link directly to design FMEAs to ensure comprehensive risk control.

  • Let's Combinate · 19m

    073 - Anatomy of a Hazard, Clifton Ericcson, ISO 14971/24971 Risk Management with Naveen Agarwal

    Naveen Agarwal of Creative Analytics Solutions explains the 'Anatomy of a Hazard' using Clifton Ericcson’s HS-IM-TTO model to clarify ISO 14971 risk management for medical devices. He argues that hazards are non-linear system properties rather than simple linear sequences, requiring a distinction between hazard source, initiating mechanisms, and target-threat outcomes. Agarwal advocates for separating failure analysis (FMEA) from hazard-harm analysis to manage complexity and improve completeness in risk files.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.